AGI therapy for postprandial hyperglycemia.
Apelian
A
A
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents